Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives--results of isotope dilution mass spectrometry measurements
- PMID: 9724072
- DOI: 10.1530/eje.0.1390167
Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives--results of isotope dilution mass spectrometry measurements
Abstract
Objectives: A new method for the quantitative determination of 17alpha-ethinylestradiol-17beta (EE2) in serum is presented here based on the principle of isotope dilution mass spectrometry (IDMS) with [13C]EE2 as internal standard. The technique was used to determine the concentration profiles of EE2 in the serum of female subjects who had taken oral contraceptives with different progestin components. The method has proved to be very reliable with respect to trueness, specificity, precision and detection sensitivity and offers considerable advantages compared with the immunological methods of measurement used to date.
Study design: Forty-seven female volunteers took two different oral contraceptives containing EE2 combined with different progestins in accordance with a cross-over design. After the administration of 30 microg EE2 combined with 75 microg gestodene (EE2/GSD) or 150 microg desogestrel (EE2/DES), blood samples were taken from the subjects on certain days and in certain previously specified cycles in the course of 12 h after medication.
Results and conclusions: The biometric analysis of the results showed that the concentration profiles of EE2 were in their statistics, significantly equivalent after the administration of either of the two oral contraceptives. The sometimes contradictory results found in former studies after the administration of the different contraceptives were presumably due to the methodological shortcomings of the radioimmunological measurement technique. With the use of the highly accurate and specific technique of IDMS it can now be unequivocally established that the different progestins in the tested oral contraceptives have no influence on the bioavailability of EE2 (area under EE2 serum concentration curves, as usually defined in pharmacokinetics).
Similar articles
-
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.Contraception. 1997 Mar;55(3):131-7. doi: 10.1016/s0010-7824(97)00025-5. Contraception. 1997. PMID: 9115000 Clinical Trial.
-
Desogestrel, norgestimate, and gestodene: the newer progestins.Ann Pharmacother. 1995 Jul-Aug;29(7-8):736-42. doi: 10.1177/106002809502907-817. Ann Pharmacother. 1995. PMID: 8520092 Review.
-
Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.Contraception. 1993 Mar;47(3):263-81. doi: 10.1016/0010-7824(93)90043-7. Contraception. 1993. PMID: 8462317 Clinical Trial.
-
The effects on hemostasis of oral contraceptives containing desogestrel.Am J Obstet Gynecol. 1993 Mar;168(3 Pt 2):1047-52. doi: 10.1016/0002-9378(93)90336-h. Am J Obstet Gynecol. 1993. PMID: 8447359 Review.
-
Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.Contraception. 1993 Oct;48(4):303-22. doi: 10.1016/0010-7824(93)90077-k. Contraception. 1993. PMID: 8222659
Cited by
-
Ovarian Hormones and Reward Processes in Palatable Food Intake and Binge Eating.Physiology (Bethesda). 2020 Jan 1;35(1):69-78. doi: 10.1152/physiol.00013.2019. Physiology (Bethesda). 2020. PMID: 31799907 Free PMC article. Review.
-
Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.Br J Clin Pharmacol. 2000 Oct;50(4):333-7. doi: 10.1046/j.1365-2125.2000.00271.x. Br J Clin Pharmacol. 2000. PMID: 11012556 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources